down arrow

Neurocrine Biosciences, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64125C1099
USD
154.22
1.74 (1.14%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
2,589.70
2,232.00
1,707.80
1,374.00
1,126.20
636.92
Shareholder's Funds
2,589.70
2,232.00
1,707.80
1,374.00
1,126.20
636.92
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
40.60
202.10
186.80
351.60
328.20
417.09
Secured Loans
40.60
202.10
186.80
351.60
328.20
417.09
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-485.70
-362.60
-305.90
-315.10
-319.40
0.00
Other Long Term Liabilities
749.6
443.2
156
117.6
104.1
103.83
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
749.60
443.20
156.00
452.70
422.00
103.83
Current Liabilities
Trade Payables
110.00
108.90
76.30
51.50
39.40
46.21
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
507.70
654.80
537.70
245.80
186.50
565.29
Total Liabilities
3,847.00
3,330.00
2,401.50
2,072.50
1,734.70
1,306.04
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
698.50
430.30
211.90
207.70
169.10
149.84
Less: Accumulated Depreciation
106.50
83.00
66.30
51.90
41.70
33.56
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
592.00
347.30
145.60
155.80
127.40
116.28
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
872.30
857.40
401.50
624.40
268.50
358.73
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
1.80
41.60
25.00
4.40
3.20
0.00
Total Non-Current Assets
2,122.30
1,723.00
948.00
1,099.70
718.50
475.01
Current Assets Loans & Advances
Current Investments
843.10
780.50
726.40
370.50
613.90
558.25
Inventories
57.40
38.30
35.10
30.50
28.00
17.29
Sundry Debtors
479.10
439.30
350.00
185.50
157.10
126.58
Cash and Bank
233.00
251.10
262.90
340.80
187.10
112.28
Other Current Assets
1,612.60
1,509.20
1,374.40
927.30
986.10
814.39
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
1,724.70
1,607.00
1,453.50
972.80
1,016.20
831.03
Net Current Assets (Including Current Investments)
1,217.00
952.20
915.80
727.00
829.70
265.75
Total Current Assets Excluding Current Investments
1,724.70
1,607.00
1,453.50
972.80
1,016.20
831.03
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
3,847.00
3,330.00
2,401.50
2,072.50
1,734.70
1,306.04
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
40.60
202.10
186.80
351.60
328.20
417.09
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is 69.13% vs 184.10% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is 70.46% vs 138.53% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is 1.74% vs 113.55% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 7.32% vs 10.56% in Dec 2023

Compare Balance Sheet Results of Neurocrine Biosciences, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
2,589.70
1,527.74
1,061.96
69.51%
Shareholder's Funds
2,589.70
1,527.74
1,061.96
69.51%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
40.60
1,150.40
-1,109.80
-96.47%
Secured Loans
40.60
1,150.40
-1,109.80
-96.47%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-485.70
0
-485.70
0.00%
Other Long Term Liabilities
749.60
566.62
182.98
32.29%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
749.60
1,703.75
-954.15
-56.00%
Current Liabilities
Trade Payables
110.00
214.44
-104.44
-48.70%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
507.70
731.68
-223.98
-30.61%
Total Liabilities
3,847.00
3,963.17
-116.17
-2.93%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
698.50
722.79
-24.29
-3.36%
Less: Accumulated Depreciation
106.50
234.15
-127.65
-54.52%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
592.00
488.65
103.35
21.15%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
872.30
152.45
719.85
472.19%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
1.80
217.34
-215.54
-99.17%
Total Non-Current Assets
2,122.30
889.71
1,232.59
138.54%
Current Assets Loans & Advances
Current Investments
843.10
251.78
591.32
234.86%
Inventories
57.40
749.96
-692.56
-92.35%
Sundry Debtors
479.10
601.99
-122.89
-20.41%
Cash and Bank
233.00
1,103.01
-870.01
-78.88%
Other Current Assets
1,612.60
2,754.48
-1,141.88
-41.46%
Short Term Loans and Advances
0
47.74
-47.74
-100.00%
Total Current Assets
1,724.70
3,073.46
-1,348.76
-43.88%
Net Current Assets (Including Current Investments)
1,217.00
2,341.78
-1,124.78
-48.03%
Total Current Assets Excluding Current Investments
1,724.70
3,073.46
-1,348.76
-43.88%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
3,847.00
3,963.17
-116.17
-2.93%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
40.60
1,150.40
-1,109.80
-96.47%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 0.00 Million
in Dec 2024

Figures in Million
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 749.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 69.13% vs 184.10% in Dec 2023

Annual - Fixed Assets
Fixed Assets 592.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 70.46% vs 138.53% in Dec 2023

Annual - Investments
Investments 872.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.74% vs 113.55% in Dec 2023

Annual - Current Assets
Current Assets 1,724.70 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.32% vs 10.56% in Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."